Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.
暂无分享,去创建一个
[1] S. Shen,et al. Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice. , 2016, Biomaterials.
[2] N. Mitsakakis,et al. Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[3] K. Nicolay,et al. Noninvasive visualization of tumoral fibrin deposition using a peptidic fibrin-binding single photon emission computed tomography tracer. , 2015, Molecular pharmaceutics.
[4] A. Rabinstein,et al. Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke , 2015, The Neurohospitalist.
[5] Liping Tang,et al. Optical imaging of fibrin deposition to elucidate participation of mast cells in foreign body responses. , 2014, Biomaterials.
[6] Ameya R. Kirtane,et al. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. , 2013, Advanced drug delivery reviews.
[7] Triantafyllos Stylianopoulos,et al. Combining two strategies to improve perfusion and drug delivery in solid tumors , 2013, Proceedings of the National Academy of Sciences.
[8] Robert D. Brown,et al. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[9] J. Panyam,et al. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. , 2013, Biomaterials.
[10] W. Powers,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[11] Triantafyllos Stylianopoulos,et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors , 2012, Proceedings of the National Academy of Sciences.
[12] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[13] Ameya R. Kirtane,et al. Folic acid functionalized nanoparticles for enhanced oral drug delivery. , 2012, Molecular pharmaceutics.
[14] Carlos Cuevas,et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[15] A. Turpie,et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. , 2012, The New England journal of medicine.
[16] Triantafyllos Stylianopoulos,et al. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.
[17] J. Panyam,et al. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery. , 2010, Molecular pharmaceutics.
[18] Edrun A. Schnell,et al. Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. , 2010, Anticancer research.
[19] J. Zivin. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA) , 2009, Annals of neurology.
[20] J. Panyam,et al. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[21] Matthias Schäfer,et al. Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.
[22] P. Artursson,et al. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.
[23] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[24] G. S. Hoo,et al. Thrombolytic Therapy for Massive Pulmonary Embolism in a Patient With a Known Intracranial Tumor , 2006, Journal of intensive care medicine.
[25] C. de Lange Davies,et al. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts , 2005, British Journal of Cancer.
[26] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[27] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.
[28] B. Lewis,et al. Thrombolysis in patients with a brain tumour , 2004, Heart.
[29] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[30] A. Unal,et al. A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer , 2004, Journal of thrombosis and haemostasis : JTH.
[31] C. Davies,et al. Collagenase Increases the Transcapillary Pressure Gradient and Improves the Uptake and Distribution of Monoclonal Antibodies in Human Osteosarcoma Xenografts , 2004, Cancer Research.
[32] Rakesh K. Jain,et al. Pathology: Cancer cells compress intratumour vessels , 2004, Nature.
[33] D. Jackson,et al. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. , 2002, Cancer research.
[34] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[35] T. Bugge,et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.
[36] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[37] R K Jain,et al. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.
[38] D. Collen. Fibrin-selective thrombolytic therapy for acute myocardial infarction. , 1996, Circulation.
[39] B. Teicher. Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.
[40] A. Brugarolas,et al. Urokinase combination chemotherapy in small cell lung cancer. A phase II study , 1992, Cancer.
[41] L. Zacharski,et al. The role of fibrin in tumor metastasis , 1992, Cancer and Metastasis Reviews.
[42] H. Dvorak,et al. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. , 1989, The American review of respiratory disease.
[43] P. Okunieff,et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.
[44] H. Dvorak,et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. , 1989, Biochimica et biophysica acta.
[45] H. Dvorak,et al. Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. , 1988, Cancer research.
[46] H. Dvorak,et al. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. , 1988, The American journal of pathology.
[47] W. Henderson,et al. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. , 1981, JAMA.
[48] S. Shukla,et al. Heparin and chemotherapy in the management of inoperable lung carcinoma , 1975, Cancer.
[49] A. Brugarolas,et al. The role of heparin in the chemotherapy of solid tumors: preliminary clinical trial in carcinoma of the lung. , 1972, Cancer chemotherapy reports.
[50] D. Lu,et al. Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. , 2007, Medical hypotheses.
[51] J. Degen,et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.
[52] H. Dvorak,et al. Fibrin as a component of the tumor stroma: origins and biological significance , 2004, Cancer and Metastasis Reviews.
[53] V. Torchilin. Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.
[54] S. Goldhaber. Contemporary pulmonary embolism thrombolysis. , 1995, Chest.